Active Pharmaceutical Ingredient (APIs)
Active Pharmaceutical Ingredients (APIs) are the essential components in pharmaceutical drugs responsible for producing the desired therapeutic effects. These are the active substances that interact with specific receptors or target molecules in the body to elicit the intended physiological or therapeutic response.


In the realm of pharmaceuticals, all drugs consist of two fundamental components:
- The API serves as the primary ingredient, derived from raw materials with a defined strength and chemical concentration.
The excipient encompasses substances other than the drug itself, aiding in the delivery of the medication into the system.
APIs play a crucial role in the efficacy and safety of pharmaceutical products, as they are the key players in determining the therapeutic outcomes of the drugs. Understanding the significance of APIs and their interactions within the body is essential for ensuring the effectiveness and quality of pharmaceutical treatments.
Active Pharmaceutical Ingredients (APIs)
- Pregabalin (IP): An anticonvulsant and neuropathic pain agent. Pregabalin is included in the Indian Pharmacopoeia.
- Fluconazole (IP): An antifungal medication. Fluconazole is included in the Indian Pharmacopoeia.
- Citicoline Sodium (IP, USP): Used in the treatment of cognitive impairments and neurological disorders. Citicoline Sodium is included in both the Indian Pharmacopoeia and the United States Pharmacopeia.
- Riboflavin (IP): Also known as Vitamin B2, it’s essential for energy production and metabolism. Riboflavin is included in the Indian Pharmacopoeia.
- Sodium Stearyl Fumarate (Excipient): A lubricant used in tablet and capsule formulations to prevent ingredients from sticking during production.
- Nebivolol (IP): A beta-blocker used to treat high blood pressure. Nebivolol is included in the Indian Pharmacopoeia.
- Adapalene: A topical retinoid used in the treatment of acne.
- Amiodarone Hydrochloride: An antiarrhythmic agent used to treat and prevent various types of cardiac arrhythmias.
- Artemether (IP): An antimalarial drug used in combination therapies. Artemether is included in the Indian Pharmacopoeia.
- Telmisartan (IP, BP, USP, EP): An angiotensin II receptor antagonist used to treat high blood pressure. Telmisartan is included in the Indian Pharmacopoeia, British Pharmacopoeia, United States Pharmacopeia, and European Pharmacopoeia.
- Oxcarbazepine (IP, USP): An anticonvulsant used to treat epilepsy. Oxcarbazepine is included in both the Indian Pharmacopoeia and the United States Pharmacopeia.
- Teneligliptin Hydrobromide Hydrate (IP): A DPP-4 inhibitor used in the management of type 2 diabetes. Teneligliptin Hydrobromide Hydrate is included in the Indian Pharmacopoeia.
- Lumefantrine (IP, USP): An antimalarial drug used in combination with artemether. Lumefantrine is included in both the Indian Pharmacopoeia and the United States Pharmacopeia.
- Croscarmellose Sodium (IP, USP): A super disintegrant used in pharmaceutical formulations to facilitate tablet disintegration. Croscarmellose Sodium is included in both the Indian Pharmacopoeia and the United States Pharmacopeia.
- Tacrolimus (USP, EP): An immunosuppressant used mainly after organ transplants to lower the risk of organ rejection. Tacrolimus is included in the United States Pharmacopeia and the European Pharmacopoeia.